# SAAL1

## Overview
SAAL1 (serum amyloid A-like 1) is a gene that encodes a protein involved in critical cellular processes, particularly those related to inflammation and immune response regulation. The protein encoded by SAAL1 is primarily active in the cytoplasm and is associated with the hepatocyte growth factor (HGF)/Met signaling pathway, influencing cell proliferation, migration, and survival. It plays a significant role in the phosphorylation cascade of the PI3K/Akt/mTOR pathway, which is essential for cell growth and survival (Chu2020Identification). SAAL1's interactions with key signaling components suggest its involvement in regulating cell cycle progression and cellular responses to external stimuli, thereby contributing to immune response modulation and inflammation control (Chu2020Identification). The protein's role in these pathways highlights its potential as a therapeutic target, particularly in diseases such as cancer and arthritis, where its expression and interactions are altered (Sato2011Overexpression; Tong2023The).

## Structure


## Function
SAAL1 (serum amyloid A-like 1) is a gene that encodes a protein involved in various cellular processes, particularly in the context of inflammation and immune response regulation. In healthy human cells, SAAL1 is primarily active in the cytoplasm, where it plays a role in modulating signal transduction pathways that are crucial for maintaining cellular homeostasis and organismal health (Chu2020Identification). 

The protein is associated with the hepatocyte growth factor (HGF)/Met signaling pathway, which is known to influence cell proliferation, migration, and survival. SAAL1 interacts with key components of this pathway, such as mTOR, and is involved in the phosphorylation cascade of the PI3K/Akt/mTOR pathway, which is essential for cell growth and survival (Chu2020Identification). 

SAAL1's involvement in these pathways suggests its role in regulating cell cycle progression and cellular responses to external stimuli. By modulating these signaling pathways, SAAL1 contributes to the regulation of immune responses and inflammation, which are critical for maintaining the balance between normal cellular function and the body's defense mechanisms against disease (Chu2020Identification).

## Clinical Significance
SAAL1 (serum amyloid A like 1) has been implicated in various diseases due to its altered expression levels and interactions. In lung adenocarcinoma (LAC), SAAL1 is overexpressed and associated with poor prognosis, including shorter overall survival, disease-specific survival, and progression-free intervals. Its expression correlates with critical cellular processes such as DNA replication, cell cycle regulation, and DNA repair, and it is linked to the immune microenvironment in LAC, affecting various immune cell types and scores (Tong2023The).

In the context of rheumatoid arthritis (RA) and osteoarthritis (OA), the gene, also known as SPACIA1, is involved in the proliferation of synovial fibroblasts, contributing to synovitis progression. Overexpression of SPACIA1/SAAL1 in synovial fibroblasts is linked to increased synovial lining thickness and inflammation. Inhibition of its expression can reduce fibroblast proliferation, suggesting its potential as a therapeutic target in these conditions (Sato2011Overexpression).

Research also indicates that SPACIA1/SAAL1 influences the expression of cyclin-dependent kinase 6 (CDK6), a key factor in cell cycle regulation, further implicating its role in synovial proliferation and arthritis progression (Fujii2018SPACIA1SAAL1).

## Interactions
SAAL1 (serum amyloid A like 1) is involved in various protein interactions that play significant roles in cancer progression. In hepatocellular carcinoma (HCC), SAAL1 interacts with the mTOR protein, particularly when cells are stimulated with hepatocyte growth factor (HGF). This interaction is part of the HGF/Met-driven Akt/mTOR signaling pathway, which is crucial for oncogenic processes in HCC. Although the interaction between SAAL1 and mTOR is described as weak and transient, it is significant enough to influence the pathway's activity, affecting cell migration, invasion, and proliferation (Chu2020Identification).

In lung adenocarcinoma (LAC), SAAL1 is associated with a network of genes involved in cell cycle regulation and mitotic processes. While specific protein interactions in LAC are not detailed, SAAL1's role in regulating proteins like cyclin D1 and Bcl-2 suggests it may interact with these or related proteins to influence cell cycle progression and apoptosis (Tong2023The).

Overall, SAAL1's interactions, particularly with mTOR in HCC, highlight its potential as a therapeutic target due to its involvement in critical signaling pathways that drive cancer progression (Chu2020Identification).


## References


[1. (Sato2011Overexpression) Tomoo Sato, Ryoji Fujii, Koji Konomi, Naoko Yagishita, Satoko Aratani, Natsumi Araya, Hiroyuki Aono, Kazuo Yudoh, Noboru Suzuki, Moroe Beppu, Yoshihisa Yamano, Kusuki Nishioka, and Toshihiro Nakajima. Overexpression of spacia1/saal1, a newly identified gene that is involved in synoviocyte proliferation, accelerates the progression of synovitis in mice and humans. Arthritis &amp; Rheumatism, 63(12):3833â€“3842, November 2011. URL: http://dx.doi.org/10.1002/art.30617, doi:10.1002/art.30617. This article has 9 citations.](https://doi.org/10.1002/art.30617)

[2. (Tong2023The) Song Tong, Ni Jiang, Jun-Hao Wan, Chong-Rui Chen, Si-Hua Wang, Chuang-Yan Wu, Qiang Guo, Xiao-Yue Xiao, Huan Huang, and Ting Zhou. The effects of the prognostic biomarker saal1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma. BMC Cancer, March 2023. URL: http://dx.doi.org/10.1186/s12885-023-10741-5, doi:10.1186/s12885-023-10741-5. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-023-10741-5)

[3. (Chu2020Identification) Pei-Yi Chu, Shiao-Lin Tung, Kuo-Wang Tsai, Fang-Ping Shen, and Shih-Hsuan Chan. Identification of the novel oncogenic role of saal1 and its therapeutic potential in hepatocellular carcinoma. Cancers, 12(7):1843, July 2020. URL: http://dx.doi.org/10.3390/cancers12071843, doi:10.3390/cancers12071843. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12071843)

[4. (Fujii2018SPACIA1SAAL1) Ryoji Fujii, Rie Komatsu, Tomoo Sato, Iwao Seki, Koji Konomi, Hiroyuki Aono, Hisateru Niki, Kazuo Yudoh, Kusuki Nishioka, and Toshihiro Nakajima. Spacia1/saal1 deletion results in a moderate delay in collagen-induced arthritis activity, along with mrna decay of cyclin-dependent kinase 6 gene. International Journal of Molecular Sciences, 19(12):3828, November 2018. URL: http://dx.doi.org/10.3390/ijms19123828, doi:10.3390/ijms19123828. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms19123828)